Retained Earnings (Accumulated Deficit) in USD of Can-Fite BioPharma Ltd. from Q4 2018 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Can-Fite BioPharma Ltd. quarterly Retained Earnings (Accumulated Deficit) history and change rate from Q4 2018 to Q2 2025.
  • Can-Fite BioPharma Ltd. Retained Earnings (Accumulated Deficit) for the quarter ending 30 Jun 2025 was -$171M, a 5.42% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 -$171M -$8.8M -5.42% 30 Jun 2025 6-K 28 Aug 2025
Q4 2024 -$166M -$7.88M -4.97% 31 Dec 2024 6-K 28 Aug 2025
Q2 2024 -$162M -$7.37M -4.75% 30 Jun 2024 6-K 29 Aug 2024
Q4 2023 -$158M -$7.63M -5.06% 31 Dec 2023 20-F 14 Apr 2025
Q2 2023 -$155M -$9.77M -6.72% 30 Jun 2023 6-K 31 Aug 2023
Q4 2022 -$151M -$10.2M -7.23% 31 Dec 2022 20-F 28 Mar 2024
Q2 2022 -$145M -$14.7M -11.3% 30 Jun 2022 6-K 25 Aug 2022
Q4 2021 -$141M -$15.2M -12.1% 31 Dec 2021 20-F 30 Mar 2023
Q2 2021 -$131M -$11.3M -9.48% 30 Jun 2021 6-K 26 Aug 2021
Q4 2020 -$125M -$15.2M -13.7% 31 Dec 2020 20-F 24 Mar 2022
Q2 2020 -$119M 30 Jun 2020 6-K 27 Aug 2020
Q4 2019 -$110M -$12.6M -12.9% 31 Dec 2019 20-F 25 Mar 2021
Q4 2018 -$97.7M 31 Dec 2018 6-K 01 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.